You can help expand this article with text translated from the corresponding article in German. (June 2021) Click [show] for important translation instructions.
|
Lothar Heinz Wieler (born 8 February 1961) is a German veterinarian and microbiologist who served as president of the Robert Koch Institute (RKI) from 2015 to 2023.[1] In this capacity, he advised the German Federal and State Governments on topics of public health, especially infection hazards, and on the containment of the COVID-19 pandemic.[2]
Lothar H. Wieler | |
---|---|
Born | Lothar Heinz Wieler 8 February 1961 |
Nationality | German |
Scientific career | |
Fields | |
Website | www |
Early life and education
editWieler was born in Königswinter, Germany. He studied veterinary medicine at Free University of Berlin and Ludwig Maximilian University of Munich from 1980 to 1985.[3]
Career
editFrom 1998 until 2015, Wieler worked as professor and director of the Institute of Microbiology and Epizootics at the Free University of Berlin. During that time, he spent a sabbatical at the Wellcome Sanger Institute in Hinxton under the supervision of Gordon Dougan.[3]
Early in the COVID-19 pandemic in Germany, Wieler launched Europe’s first large-scale SARS-CoV-2 antibody testing in an effort to help researchers assess infection rates and monitor the spread of the virus more effectively; the study was carried out jointly by the Robert Koch Institute, Charité and the Helmholtz Centre for Infection Research.[4]
In addition to his role at RKI, Wieler was a member of the World Health Organization's Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH) since 2018.[5] In 2020, he chaired the WHO's Committee for the Review of the International Health Regulations.[6] Also in 2020, he was appointed to the Global Leaders Group on Antimicrobial Resistance, co-chaired by Sheikh Hasina and Mia Mottley.[7]
Since 2023, Wieler has been working at the Hasso Plattner Institute.[8]
Other activities
edit- Virchow Prize for Global Health, Member of the Council (since 2022)[9]
- World Health Organization (WHO), Member of the European Advisory Committee on Health Research (since 2018)[10]
- Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), Member of the Scientific Advisory Board (since 2016)
- Fraunhofer Institute for Telecommunications, Member of the Board of Trustees[11]
- Robert Koch Foundation, Member of the Scientific Advisory Council[12]
Awards
edit- 2024 Officer's Cross of the Order of Merit of the Federal Republic of Germany[13][14]
References
edit- ^ "RKI – President – Prof. Dr. Lothar H. Wieler". www.rki.de.
- ^ "RKI – Mission Statement". www.rki.de.
- ^ a b CV of Lothar Wieler Robert Koch Institute.
- ^ Guy Chazan and Donato Paolo Mancini (9 April 2020), Germany to run Europe’s first large-scale antibody test programme Financial Times.
- ^ Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH) World Health Organization.
- ^ Sheri Fink (12 May 2021), Experts Call for Sweeping Reforms to Prevent the Next Pandemic New York Times.
- ^ Global Leaders Group on Antimicrobial Resistance World Health Organization.
- ^ Sandra Calvez (15 June 2023), Prävention durch Digitalisierung: Was Lothar Wieler am HPI in Potsdam erreichen will Der Tagesspiegel.
- ^ Council Virchow Prize for Global Health.
- ^ European Advisory Committee on Health Research (EACHR) World Health Organization (WHO).
- ^ Board of Trustees Fraunhofer Institute for Telecommunications.
- ^ Scientific Advisory Council Robert Koch Foundation.
- ^ "Lothar Wieler mit Bundesverdienstkreuz 1. Klasse geehrt". Nationale Akademie der Wissenschaften Leopoldina (in German). 14 January 2024. Retrieved 18 January 2024.
- ^ "Verleihung des Verdienstordens der Bundesrepublik Deutschland an Klaus Cichutek und Lothar Wieler". Der Bundespräsident (in German). Retrieved 18 January 2024.